1,440
Views
6
CrossRef citations to date
0
Altmetric
Clinical Study

Potassium supplementation and long-term outcomes in chronic peritoneal dialysis patients with end-stage renal disease: a propensity score matching study

, , , , , , & show all
Pages 1594-1600 | Received 10 Jul 2015, Accepted 20 Nov 2015, Published online: 24 Oct 2016

References

  • Katerinis I, Fumeaux Z. [Hypokalemia: Diagnosis and treatment]. Rev Med Suisse. 2007;3:579–582.
  • Zanger R. Hyponatremia and hypokalemia in patients on peritoneal dialysis. Semin Dial. 2010;23:575–580.
  • Tziviskou E, Musso C, Bellizzi V, et al. Prevalence and pathogenesis of hypokalemia in patients on chronic peritoneal dialysis: One center's experience and review of the literature. Int Urol Nephrol. 2003;35:429–434.
  • Szeto CC, Chow KM, Kwan BC, et al. Hypokalemia in Chinese peritoneal dialysis patients: Prevalence and prognostic implication. Am J Kidney Dis. 2005;46:128–135.
  • Zhang R, Wang Z, Fei Y, et al. The difference in nutrient intakes between Chinese and Mediterranean, Japanese and American diets. Nutrients. 2015;7:4661–4688.
  • Kwan BC, Szeto CC. Dialysis: Hypokalaemia and cardiac risk in peritoneal dialysis patients. Nat Rev Nephrol. 2012;8:501–503.
  • Alper AB, Campbell RC, Anker SD, et al. A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure. Int J Cardiol. 2009;137:1–8.
  • Choi HY, Ha SK. Potassium balances in maintenance hemodialysis. Electrolyte Blood Press. 2013;11:9–16.
  • Xu Q, Xu F, Fan L, et al. Serum potassium levels and its variability in incident peritoneal dialysis patients: Associations with mortality. PLoS One. 2014;9:e86750.
  • Torlen K, Kalantar-Zadeh K, Molnar MZ, Vashistha T, Mehrotra R. Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. Clin J Am Soc Nephrol. 2012;7:1272–1284.
  • Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int. 2010;77:141–151.
  • Lee J, An JN, Hwang JH, et al. Effect of dialysis initiation timing on clinical outcomes: A propensity-matched analysis of a prospective cohort study in Korea. PLoS One. 2014;9:e105532.
  • Iimori S, Mori Y, Akita W, et al. Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: A propensity-matched observational study. Clin Exp Nephrol. 2012;16:930–937.
  • Wilson FP, Yang W, Machado CA, et al. Dialysis versus nondialysis in patients with AKI: A propensity-matched cohort study. Clin J Am Soc Nephrol. 2014;9:673–681.
  • Lee JE, Oh KH, Choi KH, et al. Statin therapy is associated with improved survival in incident peritoneal dialysis patients: Propensity-matched comparison. Nephrol Dial Transplant. 2011;26:4090–4094.
  • Ekundayo OJ, Adamopoulos C, Ahmed MI, et al. Oral potassium supplement use and outcomes in chronic heart failure: A propensity-matched study. Int J Cardiol. 2010;141:167–174.
  • Ahmed A, Zannad F, Love TE, et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 2007;28:1334–1343.
  • Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int. 1982;21:849–861.
  • Jung JY, Chang JH, Lee HH, Chung W, Kim S. De novo hypokalemia in incident peritoneal dialysis patients: A 1-year observational study. Electrolyte Blood Press. 2009;7:73–78.
  • Chuang YW, Shu KH, Yu TM, Cheng CH, Chen CH. Hypokalaemia: An independent risk factor of Enterobacteriaceae peritonitis in CAPD patients. Nephrol Dial Transplant. 2009;24:1603–1608.
  • Shu KH, Chang CS, Chuang YW, et al. Intestinal bacterial overgrowth in CAPD patients with hypokalaemia. Nephrol Dial Transplant. 2009;24:1289–1292.
  • Ribeiro SC, Figueiredo AE, Barretti P, Pecoits-Filho R, de Moraes TP. Low serum potassium levels increase the infectious-caused mortality in peritoneal dialysis patients: A propensity-matched score study. PLoS One. 2015;10:e0127453.
  • Ito Y, Mizuno M, Suzuki Y, et al. Long-term effects of spironolactone in peritoneal dialysis patients. J Am Soc Nephrol. 2014;25:1094–1102.
  • Yongsiri S, Thammakumpee J, Prongnamchai S, et al. Randomized, double-blind, placebo-controlled trial of spironolactone for hypokalemia in continuous ambulatory peritoneal dialysis patients. Ther Apher Dial. 2015;19:81–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.